Uranium mining activity in the U.S. is growing as the Trump administration pursues an aggressive nuclear energy expansion agenda, with new reactor approvals, extended plant licenses, and pressure on the NRC to streamline permitting. The administration's push is creating genuine demand pull for domestically sourced uranium, which has been a policy priority since Congress passed the Prohibiting Russian Uranium Imports Act.
Trump's Nuclear Push Is Driving a Real Uranium Mining Revival — These Are the Stocks That Collect
Federal policy is actively pushing uranium demand higher, and the small-cap miners with U.S. production are the direct play.

| Ticker | Company | 1-year change |
|---|---|---|
| LEU | Centrus Energy | −34.0% |
| OKLO | Oklo | −61.7% |
| SMR | NuScale Power | −56.6% |
| CEG | Constellation Energy | −23.1% |
| VST | Vistra | −18.0% |
| CCJ | Cameco | +9.6% |
Centrus is the only company with a U.S. license to enrich the advanced fuel advanced reactors need. That's not a coincidence — it's a moat.
Who cashes in: Energy Fuels UUUU is the largest U.S. uranium producer by volume and the most direct beneficiary of any domestic sourcing mandate or price support. Uranium Energy Corp UEC has been acquiring U.S. uranium assets aggressively and is positioned to ramp production quickly. Centrus Energy LEU enriches uranium and has the only U.S.-licensed HALEU enrichment facility — critical for advanced reactors. On the reactor side, Oklo OKLO and NuScale Power SMR are the two U.S.-listed advanced reactor developers that need domestic uranium supply to exist as businesses; higher uranium availability supports their project economics.
Who's exposed: Utilities that locked in long-term uranium supply contracts at lower prices — like Constellation Energy CEG and Vistra VST — face less upside from rising spot prices but also less downside. The real risk is to any company dependent on Russian or Kazakh uranium supply that hasn't yet diversified; the import ban makes that a compliance issue, not just a cost issue. Cameco CCJ, the Canadian giant, is listed in the U.S. and benefits from higher prices, but it's not a domestic producer in the policy sense.
Watch the NRC's response to Trump's executive order on radiation exposure limits — if the commission continues to resist White House direction, it signals that reactor permitting timelines won't compress as fast as the administration wants, which is the key variable for uranium demand growth.
Source: original report ↗
Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Knowing who cashed in is only half the trade.
Every catalyst has a second move — the supplier, the sector, the part already priced in. Money Racket Pro hands you that read on every policy event, plus the pre-market brief six mornings a week, before the open.
Get the edge · $40/moJoin the readers who get there before the financial press. Cancel anytime, one click.